AstraZeneca PLC, Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research

(Reuters) - AstraZeneca and Mitsubishi Tanabe Pharma said on Wednesday they said signed a three-year research collaboration into diabetic nephropathy, or kidney failure due to diabetes.

The deal will focus on early-stage research and the hope is that by working together the companies will be able to identify promising drug candidates much faster than working alone.

There is no financial commitment for the research involved and each firm will contribute equal resources at their own cost.

Hey, check out all the research scientist jobs. Post your resume today!